Metabolic syndrome and epigenetic aging : a twin study
Föhr, T., Hendrix, A., Kankaanpää, A., Laakkonen, E. K., Kujala, U., Pietiläinen, K. H., Lehtimäki, T., Kähönen, M., Raitakari, O., Wang, X., Kaprio, J., Ollikainen, M., & Sillanpää, E. (2024). Metabolic syndrome and epigenetic aging : a twin study. International Journal of Obesity, Early online. https://doi.org/10.1038/s41366-024-01466-x
Published in
International Journal of ObesityAuthors
Date
2024Discipline
Gerontologia ja kansanterveysLiikuntalääketiedeHyvinvoinnin tutkimuksen yhteisöFyysinen aktiivisuus eliniän aikanaGerontology and Public HealthSports and Exercise MedicineSchool of WellbeingPhysical activity through life spanCopyright
© 2024 the Authors
Background
Metabolic syndrome (MetS) is associated with premature aging, but whether this association is driven by genetic or lifestyle factors remains unclear.
Methods
Two independent discovery cohorts, consisting of twins and unrelated individuals, were examined (N = 268, aged 23–69 years). The findings were replicated in two cohorts from the same base population. One consisted of unrelated individuals (N = 1 564), and the other of twins (N = 293). Participants’ epigenetic age, estimated using blood DNA methylation data, was determined using the epigenetic clocks GrimAge and DunedinPACE. The individual-level linear regression models for investigating the associations of MetS and its components with epigenetic aging were followed by within-twin-pair analyses using fixed-effects regression models to account for genetic factors.
Results
In individual-level analyses, GrimAge age acceleration was higher among participants with MetS (N = 56) compared to participants without MetS (N = 212) (mean 2.078 [95% CI = 0.996,3.160] years vs. −0.549 [−1.053,−0.045] years, between-group p = 3.5E-5). Likewise, the DunedinPACE estimate was higher among the participants with MetS compared to the participants without MetS (1.032 [1.002,1.063] years/calendar year vs. 0.911 [0.896,0.927] years/calendar year, p = 4.8E-11). An adverse profile in terms of specific MetS components was associated with accelerated aging. However, adjustments for lifestyle attenuated these associations; nevertheless, for DunedinPACE, they remained statistically significant. The within-twin-pair analyses suggested that genetics explains these associations fully for GrimAge and partly for DunedinPACE. The replication analyses provided additional evidence that the association between MetS components and accelerated aging is independent of the lifestyle factors considered in this study, however, suggesting that genetics is a significant confounder in this association.
Conclusions
The results of this study suggests that MetS is associated with accelerated epigenetic aging, independent of physical activity, smoking or alcohol consumption, and that the association may be explained by genetics.
...
Publisher
Nature Publishing GroupISSN Search the Publication Forum
0307-0565Keywords
Publication in research information system
https://converis.jyu.fi/converis/portal/detail/Publication/202788093
Metadata
Show full item recordCollections
- Liikuntatieteiden tiedekunta [3164]
Related funder(s)
Research Council of FinlandFunding program(s)
Research costs of Academy Research Fellow, AoF; Academy Project, AoF; Research profiles, AoF; Academy Research Fellow, AoFAdditional information about funding
TF is supported by the Juho Vainio Foundation and the Yrjö Jahnsson Foundation. ES is supported by the Academy of Finland (grant numbers 341750, 346509, 260001), the Juho Vainio Foundation, the Päivikki and Sakari Sohlberg Foundation, and the Yrjö Jahnsson Foundation (6168). JK is supported by the Academy of Finland (grant numbers 213506, 308248, 312073, 336823), EC FP5 GenomEUtwin, NIH NIH/NHLBI (grant HL104125), EC MC ITN Project EPITRAIN, and the Sigrid Juselius Foundation. MO is supported by the Academy of Finland (grant numbers 328685, 307339, 297908 and 251316), EC MC ITN Project EPITRAIN, University of Helsinki Research Funds, and the Sigrid Juselius Foundation. KHP is supported by the Academy of Finland (grant numbers 272376, 266286, 314383, 335443), Finnish Medical Foundation, Finnish Diabetes Research Foundation, Novo Nordisk Foundation (NNF10OC1013354, NNF17OC0027232, NNF20OC0060547), Signe and Ane Gyllenberg Foundation, Sigrid Juselius Foundation, Government Research Funds for Helsinki University Hospital Research Funds, and the University of Helsinki. EKL was supported by the Academy of Finland (grant numbers 275323 and 330281) and the PACTS2 profiling action of the University of Jyväskylä funded by the Academy of Finland (326242). The Gerontology Research Center is a joint effort between the University of Jyväskylä and the University of Tampere. The YFS has been financially supported by the following sources: Academy of Finland (grant numbers 356405, 322098, 286284, 134309 (Eye), 126925, 121584, 124282, 255381, 256474, 283115, 319060, 320297, 314389, 338395, 330809, and 104821, 129378 (Salve), 117797 (Gendi), and 141071 (Skidi)); the Social Insurance Institution of Finland; Competitive State Research Financing of the Expert Responsibility Area of Kuopio, Tampere and Turku University Hospitals (grant X51001); the Juho Vainio Foundation; the Paavo Nurmi Foundation; the Finnish Foundation for Cardiovascular Research; the Finnish Cultural Foundation; the Sigrid Juselius Foundation; the Tampere Tuberculosis Foundation; the Emil Aaltonen Foundation; the Yrjö Jahnsson Foundation; the Signe and Ane Gyllenberg Foundation; the Diabetes Research Foundation of Finnish Diabetes Association; EU Horizon 2020 (grant 755320 for TAXINOMISIS and grant 848146 for To Aition); the European Research Council (grant 742927 for MULTIEPIGEN project); the Tampere University Hospital Supporting Foundation, Finnish Society of Clinical Chemistry; the Cancer Foundation Finland; pBETTER4U_EU (Preventing obesity through Biologically and bEhaviorally Tailored inTERventions for you; project number: 101080117); and the Jane and Aatos Erkko Foundation. The EH-Epi has been finally supported by the NIH/NHLBI grant HL104125. Open Access funding provided by University of Jyväskylä (JYU). ...License
Related items
Showing items with similar title or keywords.
-
Brief interventions in counselling for nutrition and the prevalence of metabolic syndrome in primary care adult patients
Kuninkaanniemi, Hanna (Jyväskylän yliopisto, 2018) -
Epigeneettisen ikääntymisnopeuden yhteys kuolleisuuteen
Sanchez, Riikka (2021)Biologista ikää voidaan arvioida monilla erilaisilla mittareilla. Toistaiseksi lupaavin biologinen ikäennuste saadaan epigeneettistä kelloa käyttäen. Epigeneettiset kellot perustuvat DNA:n metyloitumiseen. Kronologista ... -
Epigeneettisen ikääntymisnopeuden yhteys liikkumiskykyyn
Lankila, Hannamari (2021)Riittävä liikkumiskyky on välttämätön edellytys itsenäiselle elämälle. Kävelynopeutta ja liikkumiskykyä ylipäänsä pidetään tärkeinä toiminnallisen itsenäisyyden määrittäjinä ikääntyvillä henkilöillä, sillä heikentynyt ... -
Serum metabolic profiles in overweight and obese women with and without metabolic syndrome
Wiklund, Petri; Pekkala, Satu; Autio, Reija; Munukka, Eveliina; Xu, Leiting; Saltevo, Juha; Cheng, Shumei; Kujala, Urho; Alen, Markku; Cheng, Sulin (BioMed Central Ltd., 2014)Objective: To identify serum biomarkers through metabolomics approach that distinguishes physically inactive overweight/obese women with metabolic syndrome from those who are metabolically healthy, independent of body ... -
Does the epigenetic clock GrimAge predict mortality independent of genetic influences : an 18 year follow-up study in older female twin pairs
Föhr, Tiina; Waller, Katja; Viljanen, Anne; Sanchez, Riikka; Ollikainen, Miina; Rantanen, Taina; Kaprio, Jaakko; Sillanpää, Elina (Biomed Central, 2021)Background: Epigenetic clocks are based on DNA methylation (DNAm). It has been suggested that these clocks are useable markers of biological aging and premature mortality. Because genetic factors explain variations in both ...